Strategic CDMO Fit Scorpius Biomanufacturing offers integrated analytical testing, process development, and manufacturing for biologics, enabling fast, GMP-ready clinical programs. This positions them as a strong partner for early-stage biotech and pharma teams seeking end-to-end development and scalable manufacturing.

Recent Partnerships Recent collaborations with Tivic Health for GMP manufacturing validation and with Celltheon for cell line development demonstrate credibility and momentum. These examples support outreach to companies preparing for FDA submissions or needing end-to-end CDMO services.

Vaccine Carrier Capabilities Experience producing CRM197 conjugate vaccine carrier protein highlights a niche capability that can be cross-sold to vaccine developers and conjugate programs, differentiating Scorpius in the biologics manufacturing space.

Global Growth Signals Board expansion with Tan Sze Thuan and active business development leadership indicate growth readiness and investor confidence. Target early- and growth-stage biotech firms seeking strategic manufacturing partnerships and co-development opportunities.

US Facilities Advantage A small, agile team paired with purpose-built U.S. facilities suggests a flexible, high-touch service model and faster decision cycles, appealing to clients with tight clinical timelines who require responsive CDMO support.